NPC
INO icon

National Planning Corporation’s Inovio Pharmaceuticals INO Stock Holding History

National Planning Corporation’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-104
Closed -$11.7K – 1342
2014
Q4 		$11.7K Buy
+104
New +$12.7K ﹤0.01% 1962

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

National Planning Corporation's INO Position: Q1 2015 in Review

National Planning Corporation sold out of Inovio Pharmaceuticals (INO) in Q1 2015, closing a stake of 104 shares — an estimated $11.7K sold.

National Planning Corporation first reported a position in INO in Q4 2014 and held it in 1 quarter. The position peaked at $11.7K in Q4 2014. 98 funds tracked by Wall St. Rank hold INO as of Q1 2015.

  • National Planning Corporation reported no remaining Inovio Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 104 Inovio Pharmaceuticals shares in Q1 2015, an estimated $11.7K.
  • National Planning Corporation first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's Inovio Pharmaceuticals position peaked at $11.7K in Q4 2014.
  • 98 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.